Share-based Payment Arrangements | (2) Share-based Payment Arrangements As of March 31, 2018, the Company had two employee equity incentive plans, the 2002 employee stock option and stock incentive plan (the “ESOSIP”) and the 2011 equity incentive plan (the “2011 EIP”). No further grants can be made under the ESOSIP. The Company also has a stock compensation plan for members of its Board of Directors, the Amended and Restated 2013 Directors Stock Compensation Plan (as amended and restated as of May 17, 2016, the “2013 DSCP”). 6,000,000 shares of the Company’s common stock were authorized for issuance under the 2011 EIP and 115,000 shares of the Company’s common stock were authorized for issuance under the 2013 DSCP. The ESOSIP, 2011 EIP and 2013 DSCP are each referred to herein as a “Plan,” and, collectively, as the “Plans.” Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands): Thirteen Weeks Ended March 31, 2018 April 1, 2017 Total cost of the Plans during the period $ 3,710 $ 994 Amount of related income tax benefit recognized during the period (2,251 ) (1,127 ) Net cost of the Plans during the period $ 1,459 $ (133 ) Included in income tax benefits recognized in the thirteen-week periods ended March 31, 2018 and April 1, 2017 were income tax benefits of $50,000 and $221,000, respectively, recognized on disqualifying dispositions of the Company’s common stock by employees who obtained shares of common stock through exercises of incentive stock options. Also included in income tax benefits recognized in the thirteen-week periods ended March 31, 2018 and April 1, 2017 were excess tax benefits from stock-based awards of $1,298,000 and $563,000, respectively. As of March 31, 2018, there were 78,682 shares of the Company’s common stock reserved for issuance under the 2013 DSCP and 4,519,920 shares of the Company’s common stock reserved for issuance in the aggregate under the ESOSIP and 2011 EIP. Restricted Stock Units The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans: Number of Weighted Average Grant Date RSUs Fair Value Outstanding at December 30, 2017 387,372 $ 55.75 Granted 55,651 $ 103.47 Vested (67,971 ) $ 53.92 Forfeited (92,880 ) $ 52.36 Outstanding at March 31, 2018 282,172 $ 66.72 During the thirteen-week period ended March 31, 2018, the Company granted RSUs with a performance condition. RSUs with a performance condition granted on February 2, 2018 may vest on January 31 of 2021, 2022 and 2023 based on growth in operating income and pre-tax 10-K. The Company recognized approximately $3,153,000 and $524,000 of share-based compensation expense related to RSU awards in the thirteen-week periods ended March 31, 2018 and April 1, 2017, respectively. As of March 31, 2018, there was a maximum of $30.2 million of total unrecognized compensation cost related to RSU awards granted under the Plans with an expected average remaining life of approximately 3.5 years. With respect to RSU awards with a performance condition, the amount of future compensation expense to be recognized will be determined based on future operating results. Stock Options The following table summarizes information regarding the Company’s outstanding stock options under the Plans: Weighted Average Number of Weighted Average Remaining Aggregate Intrinsic Options per Share Term (years) Value (000s) Options outstanding at December 30, 2017 189,040 $ 49.34 Exercised (40,418 ) $ 48.42 Options outstanding at March 31, 2018 148,622 $ 49.59 3.7 $ 8,927 Options exercisable at March 31, 2018 147,622 $ 49.53 3.7 $ 8,875 The total intrinsic value of stock options exercised during the thirteen-week periods ended March 31, 2018 and April 1, 2017 was $2,463,000 and $3,620,000, respectively. As of March 31, 2018, there was no unrecognized compensation cost related to non-vested Non-vested The following table summarizes information regarding the Company’s outstanding shares of non-vested Number of Shares and Deferred Stock Weighted Average Grant Date Fair Value Non-vested 54,755 $ 78.02 Granted 16,863 $ 114.13 Vested (9,819 ) $ 65.27 Forfeited (1,757 ) $ 71.12 Non-vested 60,042 $ 90.45 The fair value of each share of non-vested non-vested As of March 31, 2018, there was $4,236,000 of total unrecognized compensation cost related to non-vested non-vested |